SCHEMBL25433507

SCHEMBL25433507

CS(=O)(=O)Nc1cccc(NC(=O)c2cnn(-c3ncccn3)c2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHX9 Q08211 1/20 0.70
ALKBH1 Q13686 1/20 0.49
HPGD P15428 1/20 0.48
NAMPT P43490 1/20 0.47
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
EGFR P00533 7/20 0.44
FGFR1 P11362 7/20 0.44
KDR P35968 7/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
ATR Q13535 1/20 0.41
POLB P06746 1/20 0.41
MALT1 Q9UDY8 1/20 0.41
PIP4K2A P48426 1/20 0.41
PIP4K2B P78356 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30543989 1.00 DHX9 (0.70) DHX9ALKBH1HPGDNAMPTALDH1A1
SCHEMBL25433112 0.88 DHX9 (0.66) DHX9HPGDNAMPTALDH1A1SMN1; SMN2
SCHEMBL30543942 0.88 DHX9 (0.66) DHX9HPGDNAMPTALDH1A1SMN1; SMN2
SCHEMBL30535406 0.87 DHX9 (0.53) DHX9ALKBH1HPGDNAMPTALDH1A1
SCHEMBL25429881 0.87 DHX9 (0.53) DHX9ALKBH1HPGDNAMPTALDH1A1
SCHEMBL25430970 0.85 DHX9 (0.71) DHX9HPGDALDH1A1SMN1; SMN2EGFR
SCHEMBL30543980 0.85 DHX9 (0.71) DHX9HPGDALDH1A1SMN1; SMN2EGFR
SCHEMBL25430770 0.77 DHX9 (0.52) DHX9ALKBH1HPGDNAMPTALDH1A1
SCHEMBL25431256 0.77 DHX9 (0.52) DHX9ALKBH1HPGDNAMPTALDH1A1
SCHEMBL30535132 0.77 DHX9 (0.52) DHX9ALKBH1HPGDNAMPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 WO claimed
EP-4479380-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 EP disclosed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed